RxDoctor Payments Data

Robert Bundy, MD

Family Medicine · Mooresville, NCNPI 1518946458

Payments from drug & device makers

$11,319in general payments, 2019–2025

Across 694 payments — averaging $16.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$1K
  • AstraZeneca$1K
  • Pfizer$1K
  • GSK$938
  • Amgen$593
  • plus $5K from 51 others

What the payments were for

  • Food & beverage$11,319100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk102$1,308
AbbVie(2 entities)83$1,216
AstraZeneca34$1,173
Pfizer68$1,031
GSK52$938
Amgen40$593
Boehringer Ingelheim34$526
Bayer32$484
Novartis26$428
Johnson & Johnson20$299
Esperion Therapeutics, Inc.11$245
Lilly USA, LLC16$225
Kowa Pharmaceuticals America, Inc.17$209
Sanofi-aventis U.S. LLC10$189
Abbott8$176
Amarin Pharma, Inc.12$173
Merck12$163
Exact Sciences2$130
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC8$111
Takeda Pharmaceuticals U.S.A., Inc.7$100
Biohaven Pharmaceutical Holding Company Ltd.5$97
Idorsia Pharmaceuticals US Inc6$95
Astellas Pharma US Inc5$89
Neos Therapeutics, LP6$87
Eisai Inc.6$86
Teva Pharmaceuticals USA, Inc.5$77
Tris Pharma Inc5$67
Lundbeck LLC3$66
IBSA Pharma Inc.4$65
Ironwood Pharmaceuticals, Inc4$65
Daiichi Sankyo Inc.3$60
Biohaven Pharmaceuticals, Inc.4$59
Genentech USA, Inc.3$45
Amneal Pharmaceuticals LLC3$45
Dexcom, Inc.2$41
Grifols USA, LLC2$40
Verity Pharmaceuticals Inc.2$40
Phathom Pharmaceuticals, Inc.4$39
E.r. Squibb & Sons, L.L.C.3$39
Almatica Pharma LLC3$35
Otsuka America Pharmaceutical, Inc.2$35
Braintree Laboratories, Inc.2$32
Inspire Medical Systems, Inc.1$32
Ironshore Pharmaceuticals Inc.2$31
Adlon Therapeutics L.p.2$29
Hikma Pharmaceuticals USA2$27
Supernus Pharmaceuticals, Inc.1$24
Corium, LLC1$23
Masimo Corporation1$21
Sumitomo Pharma America, Inc.1$21
Upsher-smith Laboratories LLC1$16
Hologic Sales And Service, LLC1$14
Antares Pharma, Inc.1$13
Shire North American Group Inc1$13
Dermira, Inc.1$12
Sunovion Pharmaceuticals Inc.1$12
Cranial Technologies, Inc1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,319 in reported general payments places this provider in the 95th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$234,324
Medicare patients
466
Services billed
3,468

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin207$232,394
FarxigaDapagliflozin Propanediol167$159,328
OzempicSemaglutide125$149,193
EliquisApixaban166$135,473
MounjaroTirzepatide95$123,261
Trelegy ElliptaFluticasone/Umeclidin/Vilanter105$90,490
Repatha SureclickEvolocumab89$83,945
Breztri AerosphereBudesonide/Glycopyr/Formoterol102$64,367
MyrbetriqMirabegron71$41,891
XareltoRivaroxaban41$36,280
JanuviaSitagliptin Phosphate36$29,158
TrulicityDulaglutide23$26,618
CreonLipase/Protease/Amylase13$26,260
GemtesaVibegron42$23,794
LinzessLinaclotide31$22,661

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$526$249,044220 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,173$223,695269 claims
Lilly USA, LLCMounjaro, Trulicity$225$149,879118 claims
Novo NordiskOzempic$1,308$149,193125 claims
PfizerEliquis, Premarin$1,031$140,572177 claims
GSKTrelegy Ellipta, Breo Ellipta$938$102,362129 claims
AbbVieCreon, Linzess, Vraylar, Namzaric$1,216$65,55068 claims
Astellas Pharma US IncMyrbetriq$89$41,89171 claims
MerckJanuvia, Belsomra$163$40,50054 claims
Johnson & JohnsonXarelto$299$36,28041 claims
Sumitomo Pharma America, Inc.Gemtesa$21$23,79442 claims
Kowa Pharmaceuticals America, Inc.Livalo$209$11,54713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Mooresville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →